³ëº¸ÅؾƽþÆÄÚ¸®¾Æ(ÁÖ)

[Novotech] CRA FT(I/II)/ CRA II,III, S/PCRA

¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç

´ã´ç¾÷¹« ÀÚ°Ý¿ä°Ç Àοø
  • Monitoring experience in PMS, OS or early phase studies would be welcome.
  • A strong track record of performing visits to sites according to the Clinical Monitoring Plan 
  • Strong communication skill both in written and spoken Korean & English 
  • Excellent interpersonal and team collaboration skill with a genuine commitment to contributing to the development of innovative treatment

[ÀÚ°Ý¿ä°Ç]

°æ·Â»çÇ×: °æ·Â(1³â ÀÌ»ó )
Çз»çÇ×: ´ëÇб³(4³â)Á¹¾÷
Á÷¹«±â¼ú: ÀÓ»ó


[¿ì´ë»çÇ×]

Àü°ø°è¿­: ÀÇ/¾àÇа迭
¿Ü±¹¾î: ¿µ¾î È¸È­°¡´É,µ¶ÇØ°¡´É,ÀÛ¹®°¡´É
¿ì´ë»çÇ×: ÇØ´çÁ÷¹«ÀÎÅÏ°æ·ÂÀÚ

11 ¸í

±Ù¹«Á¶°Ç

  • °í¿ëÇüÅÂ: Á¤±ÔÁ÷(¼ö½À±â°£6°³¿ù)
  • ÀαÙÀüö¿ª: ¼­¿ï2È£¼± »ï¼º(¹«¿ª¼¾ÅÍ) (5¹ø Ãⱸ¿¡¼­ 400mÀ̳»)
  • ±Þ¿©Á¶°Ç: ¿¬ºÀ ÇùÀÇ ÈÄ °áÁ¤

ÀüÇü´Ü°è ¹× Á¦Ãâ¼­·ù

  • ÀüÇü´Ü°è: ¼­·ùÀüÇü > Æù½ºÅ©¸®´× > È­»ó¸éÁ¢ÁøÇà > ·¹ÆÛ·±½º üũ > ÃÖÁ¾ÇÕ°Ý
  • Ãß°¡ Á¦Ãâ¼­·ù
    ÀÚÀ¯¾ç½ÄÀÇ ¿µ¹®À̷¼­(MS-Word, PDF)

Á¢¼ö¹æ¹ý

ä¿ë½Ã

  • Á¢¼ö¹æ¹ý: ÀÚ»ç ȨÆäÀÌÁö
  • Á¢¼ö¾ç½Ä: ÀÚÀ¯¾ç½Ä

±âŸ À¯ÀÇ»çÇ×

  • ÀÔ»çÁö¿ø¼­ ¹× Á¦Ãâ¼­·ù¿¡ ÇãÀ§»ç½ÇÀÌ ÀÖÀ» °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.